XILONG SCIENTIFIC(SZ:002584) Xin Lang Cai Jing·2025-11-21 03:29Core Viewpoint - Xilong Science has shown a mixed performance in stock price and financial results, with a notable increase in stock price this year but a decline in revenue and net profit for the first nine months of 2025 [1][2]. Group 1: Stock Performance - On November 21, Xilong Science's stock rose by 2.05%, reaching 8.95 CNY per share, with a trading volume of 252 million CNY and a turnover rate of 6.08%, resulting in a total market capitalization of 5.238 billion CNY [1]. - Year-to-date, Xilong Science's stock price has increased by 24.48%, with a 3.95% rise over the last five trading days and a 4.19% increase over the last 20 days, while it has decreased by 2.72% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" five times this year, with the most recent appearance on September 24, where it recorded a net purchase of 3.6192 million CNY [1]. Group 2: Financial Performance - For the period from January to September 2025, Xilong Science reported a revenue of 5.324 billion CNY, a year-on-year decrease of 11.13%, and a net profit attributable to shareholders of -61.8292 million CNY, representing a year-on-year decline of 196.33% [2]. - The company's main business revenue composition includes specialized chemicals (62.60%), chemical raw materials (15.12%), electronic chemicals (9.66%), general reagents (7.71%), lithium battery cathode materials (4.00%), and raw materials and food additives (0.86%) [2]. Group 3: Shareholder Information - As of September 30, Xilong Science had 85,100 shareholders, a decrease of 2.33% from the previous period, with an average of 5,503 circulating shares per shareholder, an increase of 2.38% [2]. Group 4: Dividend Information - Since its A-share listing, Xilong Science has distributed a total of 217 million CNY in dividends, with 31.0165 million CNY distributed over the past three years [3].